Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions: Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations: City of Hope National Medical Center Duarte, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Rigshospitalet Copenhagen, Denmark

View all 25 locations

View Trial Details

Recruiting

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

NCT07407166

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

NCT04567706

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma

NCT04594187

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States

Cooper Hospital UNIV MED CTR. Camden, New Jersey, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App

NCT06675643

Conditions: Malignant Skin Neoplasm, Melanoma, Neoplasms, +10 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

NCT06548789

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations: The Angeles Clinic and Research Institute Los Angeles, California, United States

START Midwest Grand Rapids, Michigan, United States

START-New York Long Island Lake Success, New York, United States

Providence Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

NCT06599619

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysplastic Nevus Syndrome, +23 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

NCT06199713

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations: University of Wisconsin Hospitals and Clinics (UWHC) Madison, Wisconsin, United States

View Trial Details

Melanoma

Melanoma trial results

Related conditions